Cargando…
Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
Abundant evidence has demonstrated that obesity is a state of low-grade chronic inflammation that triggers the release of lipids, aberrant adipokines, pro-inflammatory cytokines, and several chemokines from adipose tissue. This low-grade inflammation underlies the development of insulin resistance a...
Autores principales: | Xu, Liang, Kitade, Hironori, Ni, Yinhua, Ota, Tsuguhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598764/ https://www.ncbi.nlm.nih.gov/pubmed/26197341 http://dx.doi.org/10.3390/biom5031563 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
por: Kitade, Hironori, et al.
Publicado: (2017) -
Chemokine Systems Link Obesity to Insulin Resistance
por: Ota, Tsuguhito
Publicado: (2013) -
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016) -
Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice
por: Gruben, Nanda, et al.
Publicado: (2014) -
Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
por: Chen, Wei, et al.
Publicado: (2018)